Cairn Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $713K | Buy |
10,328
+446
| +5% | +$30.8K | 0.37% | 43 |
|
|
2025
Q1 | $686K | Sell |
9,882
-168
| -2% | -$11.7K | 0.39% | 42 |
|
|
2024
Q4 | $865K | Sell |
10,050
-8,700
| -46% | -$749K | 0.51% | 42 |
|
|
2024
Q3 | $2.23M | Sell |
18,750
-200
| -1% | -$23.8K | 1.23% | 26 |
|
|
2024
Q2 | $2.71M | Sell |
18,950
-200
| -1% | -$28.5K | 1.58% | 26 |
|
|
2024
Q1 | $2.46M | Sell |
19,150
-30
| -0.2% | -$3.85K | 1.41% | 24 |
|
|
2023
Q4 | $1.98M | Sell |
19,180
-50
| -0.3% | -$5.17K | 1.24% | 24 |
|
|
2023
Q3 | $1.75M | Sell |
19,230
-100
| -0.5% | -$9.1K | 1.16% | 25 |
|
|
2023
Q2 | $1.56M | Sell |
19,330
-120
| -0.6% | -$9.71K | 1.01% | 27 |
|
|
2023
Q1 | $1.55M | Sell |
19,450
-17,000
| -47% | -$1.35M | 1.08% | 27 |
|
|
2022
Q4 | $2.47M | Buy |
36,450
+520
| +1% | +$35.2K | 1.84% | 18 |
|
|
2022
Q3 | $1.79M | Sell |
35,930
-1,270
| -3% | -$63.3K | 1.45% | 24 |
|
|
2022
Q2 | $2.07M | Sell |
37,200
-16,940
| -31% | -$944K | 1.61% | 23 |
|
|
2022
Q1 | $3.6M | Hold |
54,140
| – | – | 2.28% | 11 |
|
|
2021
Q4 | $3.03M | Sell |
54,140
-750
| -1% | -$42K | 2.09% | 11 |
|
|
2021
Q3 | $2.63M | Sell |
54,890
-700
| -1% | -$33.6K | 1.95% | 11 |
|
|
2021
Q2 | $2.33M | Hold |
55,590
| – | – | 1.71% | 18 |
|
|
2021
Q1 | $1.87M | Sell |
55,590
-370
| -0.7% | -$12.5K | 1.56% | 23 |
|
|
2020
Q4 | $1.95M | Sell |
55,960
-22,000
| -28% | -$768K | 1.85% | 18 |
|
|
2020
Q3 | $2.71M | Sell |
77,960
-4,290
| -5% | -$149K | 2.87% | 5 |
|
|
2020
Q2 | $2.69M | Sell |
82,250
-3,590
| -4% | -$117K | 3.27% | 3 |
|
|
2020
Q1 | $2.58M | Buy |
85,840
+30
| +0% | +$903 | 3.84% | 3 |
|
|
2019
Q4 | $2.48M | Buy |
+85,810
| New | +$2.48M | 2.46% | 5 |
|